Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Neointimal Coverage After Guiding De-escalation of Antiplatelet Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention by Optical Coherence Tomography or Angiography of STEMI Patients

NCT06339021 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT06339021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06339021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Neointimal Coverage After Guiding De-escalation of Antiplatelet Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention by Optical Coherence Tomography or Angiography of STEMI Patients
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 1, 2024
Completion date
December 1, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet de-escalation, dual antiplatelet therapy, neointimal coverage, optical coherence tomography, st elevation myocardial infarction